메뉴 건너뛰기




Volumn 368, Issue 9532, 2006, Pages 287-298

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMINOTRANSFERASE; AMYLASE; BILIRUBIN; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TRIACYLGLYCEROL; VIRUS RNA; ZIDOVUDINE;

EID: 33745988980     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69074-0     Document Type: Article
Times cited : (79)

References (20)
  • 1
    • 22844432208 scopus 로고    scopus 로고
    • British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)
    • on behalf of the BHIVA Writing Committee. published online July 1. DOI:10.1111/j.1468-1293.2005.0311b.x
    • Gazzard B., and on behalf of the BHIVA Writing Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). HIV Med (2005). published online July 1. DOI:10.1111/j.1468-1293.2005.0311b.x
    • (2005) HIV Med
    • Gazzard, B.1
  • 3
    • 3042726798 scopus 로고    scopus 로고
    • Treatment of adult HIV infection. 2004 recommendations of the International AIDS Society-USA panel
    • Yeni P., Hammer S., Hirsch M., et al. Treatment of adult HIV infection. 2004 recommendations of the International AIDS Society-USA panel. JAMA 292 (2004) 251-265
    • (2004) JAMA , vol.292 , pp. 251-265
    • Yeni, P.1    Hammer, S.2    Hirsch, M.3
  • 4
    • 0035071409 scopus 로고    scopus 로고
    • An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial
    • INITIO Co-ordinating Committee
    • INITIO Co-ordinating Committee. An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial. Control Clin Trials 22 (2001) 160-175
    • (2001) Control Clin Trials , vol.22 , pp. 160-175
  • 6
    • 0344149561 scopus 로고    scopus 로고
    • Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
    • Shafer R., Smeaton L., Robbins G., et al. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 349 (2003) 2304-2315
    • (2003) N Engl J Med , vol.349 , pp. 2304-2315
    • Shafer, R.1    Smeaton, L.2    Robbins, G.3
  • 7
    • 0345012053 scopus 로고    scopus 로고
    • Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection
    • for the AIDS Clinical Trials Group 384 Team
    • Robbins G., De Gruttola V., Shafer R., et al., for the AIDS Clinical Trials Group 384 Team. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 349 (2003) 2293-2303
    • (2003) N Engl J Med , vol.349 , pp. 2293-2303
    • Robbins, G.1    De Gruttola, V.2    Shafer, R.3
  • 9
    • 0003730887 scopus 로고
    • Division of AIDS (accessed Feb 28, 2006)
    • Division of AIDS. Table for grading severity of adult adverse experiences (August, 1992). http://rcc.tech-res-intl.com/DAIDS%20RCC%20Forms/TB_ToxicityTables_Adult_TRP_v01a.pdf (accessed Feb 28, 2006)
    • (1992) Table for grading severity of adult adverse experiences
  • 11
    • 0037092125 scopus 로고    scopus 로고
    • Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001)
    • Whitby L., Granger V., Storie I., et al. Quality control of CD4+ T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001). Cytology 50 (2002) 102-110
    • (2002) Cytology , vol.50 , pp. 102-110
    • Whitby, L.1    Granger, V.2    Storie, I.3
  • 12
    • 0027122957 scopus 로고
    • 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
    • US Centers for Disease Control and Prevention
    • US Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 (1992) 1-19
    • (1992) MMWR Recomm Rep , vol.41 , pp. 1-19
  • 13
    • 0032895405 scopus 로고    scopus 로고
    • Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases
    • Marschner I., Betensky R., DeGruttola V., Hammer S., and Kuritzkes D. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases. J AIDS 20 (1999) 220-227
    • (1999) J AIDS , vol.20 , pp. 220-227
    • Marschner, I.1    Betensky, R.2    DeGruttola, V.3    Hammer, S.4    Kuritzkes, D.5
  • 14
    • 33644792666 scopus 로고    scopus 로고
    • Update of the drug resistance mutations in HIV-1: fall 2005
    • Johnson V., Brun-Vezinet F., Clotet B., et al. Update of the drug resistance mutations in HIV-1: fall 2005. Top HIV Med 13 (2005) 125-131
    • (2005) Top HIV Med , vol.13 , pp. 125-131
    • Johnson, V.1    Brun-Vezinet, F.2    Clotet, B.3
  • 15
    • 0035075985 scopus 로고    scopus 로고
    • The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial
    • for the CPCRA 058 FIRST Trial Study Team
    • MacArthur R., Chen L., Mayers D., et al., for the CPCRA 058 FIRST Trial Study Team. The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial. Control Clin Trials 22 (2001) 176-190
    • (2001) Control Clin Trials , vol.22 , pp. 176-190
    • MacArthur, R.1    Chen, L.2    Mayers, D.3
  • 16
    • 0037182766 scopus 로고    scopus 로고
    • Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
    • for the M98-863 study team
    • Walmsley S., Bernstein B., King M., et al., for the M98-863 study team. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med 346 (2002) 2039-2046
    • (2002) N Engl J Med , vol.346 , pp. 2039-2046
    • Walmsley, S.1    Bernstein, B.2    King, M.3
  • 17
    • 0032566194 scopus 로고    scopus 로고
    • 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
    • on behalf of the BHIVA Guidelines Writing Committee
    • Gazzard B., Moyle G., and on behalf of the BHIVA Guidelines Writing Committee. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 352 (1998) 314-316
    • (1998) Lancet , vol.352 , pp. 314-316
    • Gazzard, B.1    Moyle, G.2
  • 18
    • 33746008822 scopus 로고    scopus 로고
    • Pollard R, Peterson D, Hardy D, et al. Stavudine (d4T) and didanosine (ddI) combination therapy in HIV-infected subjects: antiviral effect and safety in an on-going pilot randomized double-blinded trial. Vancouver: XI International AIDS Conference, 1996: abstract Th.B.293.
  • 19
    • 0003176164 scopus 로고    scopus 로고
    • HIV treatment guidelines
    • US Centers for Disease Control and Prevention
    • US Centers for Disease Control and Prevention. HIV treatment guidelines. MMWR Recomm Rep 47 (1998) 1-41
    • (1998) MMWR Recomm Rep , vol.47 , pp. 1-41
  • 20
    • 0038324248 scopus 로고    scopus 로고
    • Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095
    • Moyle G. Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095. AIDS Read 13 (2003) 223-227
    • (2003) AIDS Read , vol.13 , pp. 223-227
    • Moyle, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.